Skip to main content
Top

Current Cardiology Reports

Issue 4/2008

Content (13 Articles)

Late adverse events after drug-eluting stent implantation

David F. Kong, Eric L. Eisenstein, Robert A. Harrington

Optimal treatment of the diabetic patient with multivessel disease

Sameer Bansilal, Michael E. Farkouh, Valentin Fuster

Lessons learned from the CRUSADE National Quality Improvement Initiative

Eric D. Peterson, David Z. Bynum, Matthew T. Roe

Should prasugrel or clopidogrel be used in patients with ACS?

  • Clinical Trials Report

Neal S. Kleiman

Early intervention: Which patients and how early?

J. Matthew Brennan, John L. Petersen

Which heparin and how much?

Peter E. Ruchin, Marino Labinaz

Sorting through new biomarkers

Frances O. Wood, James A. de Lemos

Antiplatelet therapy in acute coronary syndromes

Colin M. Barker, Matthew J. Price

Lipid management: Considerations in acute coronary syndrome

Venkateshwar R. Polsani, Salim S. Virani, Vijay Nambi

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME